Award Number: W81XWH-10-1-0337 TITLE: Identification and Characterization of MYC Regulatory Elements: Links to Prostate Cancer
暂无分享,去创建一个
[1] E. Noonan,et al. The Immunoglobulin Heavy Chain Gene 3’ Enhancers Induce Bcl2 Deregulation and Lymphomagenesis in Murine B Cells , 2011, Leukemia.
[2] Matthew L. Freedman,et al. Analysis of the 10q11 Cancer Risk Locus Implicates MSMB and NCOA4 in Human Prostate Tumorigenesis , 2010, PLoS genetics.
[3] S. Inoue,et al. Runx2 in human breast carcinoma: its potential roles in cancer progression , 2010, Cancer science.
[4] Miguel Manzanares,et al. Allelic Variation at the 8q23.3 Colorectal Cancer Risk Locus Functions as a Cis-Acting Regulator of EIF3H , 2010, PLoS genetics.
[5] M. Nóbrega,et al. An 8q24 gene desert variant associated with prostate cancer risk confers differential in vivo activity to a MYC enhancer. , 2010, Genome research.
[6] M. Freedman,et al. Chromosome 8q24-Associated Cancers and MYC. , 2010, Genes & cancer.
[7] Deborah Hughes,et al. Genome-wide association study identifies five new breast cancer susceptibility loci , 2010, Nature Genetics.
[8] G. Coetzee,et al. 8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC , 2010, Proceedings of the National Academy of Sciences.
[9] Hongling Liao,et al. Long-range enhancers on 8q24 regulate c-Myc , 2010, Proceedings of the National Academy of Sciences.
[10] Derek Y. Chiang,et al. The landscape of somatic copy-number alteration across human cancers , 2010, Nature.
[11] Michael D. Cole,et al. Upregulation of c-MYC in cis through a Large Chromatin Loop Linked to a Cancer Risk-Associated Single-Nucleotide Polymorphism in Colorectal Cancer Cells , 2010, Molecular and Cellular Biology.
[12] E. Campo,et al. Common variants at 2q37.3, 8q24.21, 15q21.3, and 16q24.1 influence chronic lymphocytic leukemia risk , 2010, Nature Genetics.
[13] J. Houwing-Duistermaat,et al. Enrichment of Low Penetrance Susceptibility Loci in a Dutch Familial Colorectal Cancer Cohort , 2009, Cancer Epidemiology, Biomarkers & Prevention.
[14] Ali Amin Al Olama,et al. Multiple loci on 8q24 associated with prostate cancer susceptibility , 2009, Nature Genetics.
[15] A. Visel,et al. Genomic Views of Distant-Acting Enhancers , 2009, Nature.
[16] M. Pelizzo,et al. The Variant rs1867277 in FOXE1 Gene Confers Thyroid Cancer Susceptibility through the Recruitment of USF1/USF2 Transcription Factors , 2009, PLoS genetics.
[17] D. Reich,et al. Functional Enhancers at the Gene-Poor 8q24 Cancer-Linked Locus , 2009, PLoS genetics.
[18] Esko Ukkonen,et al. The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling , 2009, Nature Genetics.
[19] P. Kantoff,et al. Evaluation of the 8q24 prostate cancer risk locus and MYC expression. , 2009, Cancer research.
[20] P. Broderick,et al. The colorectal cancer risk at 18q21 is caused by a novel variant altering SMAD7 expression. , 2009, Genome research.
[21] M. Zannini,et al. The DREAM protein is associated with thyroid enlargement and nodular development. , 2009, Molecular endocrinology.
[22] S. Weinstein,et al. Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibility , 2009, Proceedings of the National Academy of Sciences.
[23] Giske Ursin,et al. FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformation. , 2009, Human molecular genetics.
[24] J. Carpten,et al. Fine mapping association study and functional analysis implicate a SNP in MSMB at 10q11 as a causal variant for prostate cancer risk. , 2009, Human molecular genetics.
[25] Kari Stefansson,et al. Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations , 2009, Nature Genetics.
[26] N. Camp,et al. Meta Association of Colorectal Cancer Confirms Risk Alleles at 8q24 and 18q21 , 2009, Cancer Epidemiology Biomarkers & Prevention.
[27] H. Duan,et al. Functional long-range interactions of the IgH 3′ enhancers with the bcl-2 promoter region in t(14;18) lymphoma cells , 2008, Oncogene.
[28] Steven Gallinger,et al. Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer , 2008, Nature Genetics.
[29] Tony Fletcher,et al. Sequence variant on 8q24 confers susceptibility to urinary bladder cancer , 2008, Nature Genetics.
[30] Olufunmilayo I Olopade,et al. MYC in breast tumor progression , 2008, Expert review of anticancer therapy.
[31] Karin M. Fredrikson,et al. Comprehensive resequence analysis of a 136 kb region of human chromosome 8q24 associated with prostate and colon cancers , 2008, Human Genetics.
[32] S. Carroll. Evo-Devo and an Expanding Evolutionary Synthesis: A Genetic Theory of Morphological Evolution , 2008, Cell.
[33] John L Hopper,et al. Multiple loci with different cancer specificities within the 8q24 gene desert. , 2008, Journal of the National Cancer Institute.
[34] B. Ponder,et al. Allele-Specific Up-Regulation of FGFR2 Increases Susceptibility to Breast Cancer , 2008, PLoS biology.
[35] Zanke,et al. Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21 , 2008, Nature Genetics.
[36] Julian Peto,et al. A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3 , 2008, Nature Genetics.
[37] W. Willett,et al. Multiple loci identified in a genome-wide association study of prostate cancer , 2008, Nature Genetics.
[38] Ali Amin Al Olama,et al. Multiple newly identified loci associated with prostate cancer susceptibility , 2008, Nature Genetics.
[39] Oliver Sieber,et al. A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer risk , 2007, Nature Genetics.
[40] J. Brooks,et al. Genomic profiling reveals alternative genetic pathways of prostate tumorigenesis. , 2007, Cancer research.
[41] Oliver Sieber,et al. A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21 , 2007, Nature Genetics.
[42] David Reich,et al. A common genetic risk factor for colorectal and prostate cancer , 2007, Nature Genetics.
[43] Steven Gallinger,et al. Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24 , 2007, Nature Genetics.
[44] M. Bollen,et al. The gene encoding the prostatic tumor suppressor PSP94 is a target for repression by the Polycomb group protein EZH2 , 2007, Oncogene.
[45] Lester L. Peters,et al. Genome-wide association study identifies novel breast cancer susceptibility loci , 2007, Nature.
[46] William Stafford Noble,et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project , 2007, Nature.
[47] W. Willett,et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer , 2007, Nature Genetics.
[48] D. Gudbjartsson,et al. Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24 , 2007, Nature Genetics.
[49] P. Fearnhead,et al. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24 , 2007, Nature Genetics.
[50] H. Duan,et al. The immunoglobulin heavy-chain gene 3′ enhancers deregulate bcl-2 promoter usage in t(14;18) lymphoma cells , 2007, Oncogene.
[51] A. Whittemore,et al. Multiple regions within 8q24 independently affect risk for prostate cancer , 2007, Nature Genetics.
[52] Nathaniel D. Heintzman,et al. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome , 2007, Nature Genetics.
[53] J. R. Reeves,et al. Prognostic Value of Prostate Secretory Protein of 94 Amino Acids and its Binding Protein after Radical Prostatectomy , 2006, Clinical Cancer Research.
[54] C. V. Jongeneel,et al. Establishment of the epithelial-specific transcriptome of normal and malignant human breast cells based on MPSS and array expression data , 2006, Breast Cancer Research.
[55] A. Gylfason,et al. A common variant associated with prostate cancer in European and African populations , 2006, Nature Genetics.
[56] V. Srikantan,et al. Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome , 2006, Oncogene.
[57] J. Tchinda,et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. , 2006, Science.
[58] C. Hill,et al. Alterations in components of the TGF-beta superfamily signaling pathways in human cancer. , 2006, Cytokine & growth factor reviews.
[59] Michael C O'Donovan,et al. Strong bias in the location of functional promoter polymorphisms , 2005, Human mutation.
[60] Lothar Hennighausen,et al. Information networks in the mammary gland , 2005, Nature Reviews Molecular Cell Biology.
[61] J. Wysolmerski,et al. Key stages of mammary gland development: Molecular mechanisms involved in the formation of the embryonic mammary gland , 2005, Breast Cancer Research.
[62] Yun-Fai Chris Lau,et al. Unopposed c‐MYC expression in benign prostatic epithelium causes a cancer phenotype , 2005, The Prostate.
[63] Ralf Küppers,et al. Mechanisms of B-cell lymphoma pathogenesis , 2005, Nature Reviews Cancer.
[64] H. Duan,et al. Histone Deacetylase Inhibitors Down-Regulate bcl-2 Expression and Induce Apoptosis in t(14;18) Lymphomas , 2005, Molecular and Cellular Biology.
[65] A. Affuso,et al. An integrated regulatory network controlling survival and migration in thyroid organogenesis. , 2004, Developmental biology.
[66] Tien Hsu,et al. Ets proteins in biological control and cancer , 2004, Journal of cellular biochemistry.
[67] A. Feinberg,et al. The history of cancer epigenetics , 2004, Nature Reviews Cancer.
[68] M. Krajnc-Franken,et al. Impaired Nipple Development and Parturition in LGR7 Knockout Mice , 2004, Molecular and Cellular Biology.
[69] M. Nóbrega,et al. Scanning Human Gene Deserts for Long-Range Enhancers , 2003, Science.
[70] Denis Duboule,et al. A Global Control Region Defines a Chromosomal Regulatory Landscape Containing the HoxD Cluster , 2003, Cell.
[71] W. Isaacs,et al. For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. Pathological and Molecular Aspects of Prostate Cancer Prostate Cancer Ii , 2022 .
[72] J. Dekker,et al. Capturing Chromosome Conformation , 2002, Science.
[73] B. Jasani,et al. Thyroid transcription factor-2 gene expression in benign and malignant thyroid lesions. , 2001, Thyroid : official journal of the American Thyroid Association.
[74] H. Clevers,et al. Linking Colorectal Cancer to Wnt Signaling , 2000, Cell.
[75] M. Dyer,et al. The role of immunoglobulin translocations in the pathogenesis of B-cell malignancies. , 2000, Blood.
[76] F. Mitelman,et al. Recurrent chromosome aberrations in cancer. , 2000, Mutation research.
[77] L. Hood,et al. Prostate-localized and androgen-regulated expression of the membrane-bound serine protease TMPRSS2. , 1999, Cancer research.
[78] E. Prochownik,et al. MYC oncogenes and human neoplastic disease , 1999, Oncogene.
[79] A. Sparks,et al. Identification of c-MYC as a target of the APC pathway. , 1998, Science.
[80] B. Desoize. Anticancer drug resistance and inhibition of apoptosis. , 1994, Anticancer research.
[81] J. Rossant,et al. Inducible expression of an hsp68-lacZ hybrid gene in transgenic mice. , 1989, Development.
[82] D. Clair,et al. Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder , 2011, Molecular Psychiatry.
[83] Peter A. Jones,et al. Epigenetics in cancer. , 2010, Carcinogenesis.
[84] L. Tanoue. Cancer Statistics, 2009 , 2010 .
[85] A. Chinnaiyan,et al. Recurrent gene fusions in prostate cancer , 2008, Nature Reviews Cancer.
[86] M. Katoh. Cancer genomics and genetics of FGFR2 (Review). , 2008, International journal of oncology.
[87] I. Wierstra,et al. The c-myc promoter: still MysterY and challenge. , 2008, Advances in cancer research.
[88] C. Hill,et al. New insights into TGF-beta-Smad signalling. , 2004, Trends in biochemical sciences.
[89] Yang Wang,et al. An alternative promoter of the human neuronal nitric oxide synthase gene is expressed specifically in Leydig cells. , 2002, The American journal of pathology.
[90] A. Khamlichi,et al. The 3' IgH regulatory region: a complex structure in a search for a function. , 2000, Advances in immunology.
[91] Martin J. S. Dyer,et al. Chromosomal translocations in cancer , 1996 .
[92] B. Herrmann,et al. Detection of messenger RNA by in situ hybridization to postimplantation embryo whole mounts. , 1993, Methods in enzymology.